Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">Forward</td><td class="align_center">Reverse</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">BACH1</td><td class="align_center">CACCGAAGGAGACAGTGAATCC</td><td class="align_center">GCTGTTCTGGAGTAAGCTTGTGC</td></tr><tr><td class="align_left">MALAT1</td><td class="align_center">AAA GCA AGG TCT CCC CAC A A G</td><td class="align_center">G G T C T G T G C T A G A T C A A A AGG</td></tr><tr><td class="align_left">GADPH</td><td class="align_center">A C C A C A G T C C A T G C C</td><td class="align_center">T C C A C C C T G T T G C</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The studied gene primer sequence.</div>

International Journal of Breast Cancer

tab1

Table 1

Table 1: Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 

Table 1 | Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 